Skip to main content
23andMe Holding Co. (ME)
NASDAQ: ME · IEX Real-Time Price · USD
0.464
+0.005 (1.11%)
At close: Apr 26, 2024, 4:00 PM
0.470
+0.006 (1.19%)
After-hours: Apr 26, 2024, 7:39 PM EDT

23andMe Holding Co. Revenue

23andMe Holding Co. had revenue of $247.99M in the twelve months ending December 31, 2023, down -19.40% year-over-year. Revenue in the quarter ending December 31, 2023 was $44.75M, a -33.15% decrease year-over-year. In the fiscal year ending March 31, 2023, 23andMe Holding Co. had annual revenue of $299.49M with 10.15% growth.

Revenue (ttm)
$247.99M
Revenue Growth
-19.40%
P/S Ratio
0.90
Revenue / Employee
$322,480
Employees
769
Market Cap
224.12M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2023299.49M27.60M10.15%
Mar 31, 2022271.89M27.97M11.47%
Mar 31, 2021243.92M-61.54M-20.15%
Mar 31, 2020305.46M-135.44M-30.72%
Mar 31, 2019440.90M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Auna S.A. 1.04B
Accuray 447.48M
Agenus 156.31M
2seventy bio 100.39M
AVITA Medical 51.57M
Foghorn Therapeutics 34.16M
uniQure 15.84M
Ovid Therapeutics 391.70K
Revenue Rankings

ME News

More News